Global Personal Genome Services Market
Global Personal Genome Services Market

Personal Genome Services Comprehensive Study by Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, Other), Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, Other), Services Type (NGS-based Services, Core Genomics Services, Biomarker Translation Services, Computational Services, Others), End User (Hospitals & Clinics, Research Centers and Academic & Government Institutes,, Pharmaceutical & Biotechnology Companies, Other) Players and Region - Global Market Outlook to 2026

Personal Genome Services Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Aug 2021 Edition 225 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Personal genome services provide consumer genomics, in the area of genomics that deals with the sequencing, analysis, and interpretation of an individual's genome. Single-nucleotide polymorphism analysis chips, and partial or whole-genome sequencing, are used at the genotyping step. Once the genotypes have been determined, the individual's variants may be compared to existing literature to assess the likelihood of trait expression, ancestry inference, and illness risk.This growth is primarily driven by Rising Number of Government Genome Projects and New Products and Innovative Service to Favor the Adoption of Sequencing.

Globally, a noticeable market trend is evident Technological Advancement in Polymerase Chain Reaction (PCR) and Next-Generation Sequencing Microarray (NGS). Major Players, such as Illumina, Inc. (United States), 23andMe (United States), Veritas Genetics (United States), Thermo Fisher Scientific (United States), Nebula Genomics (United States), 10x Genomics (United States), Agilent Technologies (United States), Invitae Corporation (United States), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (United States) and F. Hoffmann-La Roche Ltd. (Switzerland) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 17 Sep 2020, QIAGEN N.V. announced the acquisition of NeuMoDx Molecular, Inc. to enhance its strong position in automated molecular testing. NeuMoDx automation solutions based on PCR testing technology for medium and high throughput will now be included in QIAGEN's offering. QIAGEN will be willing to deliver laboratory demands in nearly any environment for molecular diagnostics owing to the NeuMoDx systems' complete integration. Both firms are expanding our product line and global distribution.
On 06 Jan 2021, Illumina and Helix announced the collaboration to improve the United States' national surveillance infrastructure in order to track the development and spread of new SARS-CoV-2 strains. The country's existing surveillance efforts to discover and characterize new variants of SARS-CoV-2 will be considerably expanded thanks to Illumina's sequencing technology and experience, as well as Helix's nationwide COVID-19 testing footprint.

Market Drivers
  • Rising Number of Government Genome Projects
  • New Products and Innovative Service to Favor the Adoption of Sequencing

Market Trend
  • Technological Advancement in Polymerase Chain Reaction (PCR) and Next-Generation Sequencing Microarray (NGS)

Restraints
  • High-Cost Implementation Associated with Personal Genome Service

Opportunities
Growth in the Personalized Medicine Market and Advancements of Gene Therapy Replacing Traditional Drugs and Surgeries
Challenges
Lack of Trained Technicians in Developing Countries

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Personal Genome Services Study Sheds Light on
— The Personal Genome Services Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Personal Genome Services industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Personal Genome Services industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Personal Genome Services Market?
The Personal Genome Services market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in Personal Genome Services Market?
Top performing companies in the Global Personal Genome Services market are Illumina, Inc. (United States), 23andMe (United States), Veritas Genetics (United States), Thermo Fisher Scientific (United States), Nebula Genomics (United States), 10x Genomics (United States), Agilent Technologies (United States), Invitae Corporation (United States), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (United States) and F. Hoffmann-La Roche Ltd. (Switzerland), to name a few.

3. Which region dominated the worldwide market for Personal Genome Services in 2020?
is dominating the Personal Genome Services Market.
Report Objectives / Segmentation Covered
By Application
  • Drug Discovery and Development
  • Diagnostics
  • Agriculture and Animal Research
  • Other
By Technology
  • Sequencing
  • PCR
  • Nucleic Acid Extraction and Purification
  • Microarray
  • Other

By Services Type
  • NGS-based Services
  • Core Genomics Services
  • Biomarker Translation Services
  • Computational Services
  • Others

By End User
  • Hospitals & Clinics
  • Research Centers and Academic & Government Institutes,
  • Pharmaceutical & Biotechnology Companies
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Chile
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Indonesia
    • Thailand
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Spain
    • Sweden
    • Belgium
    • Finland
    • Denmark
    • Russia
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of Government Genome Projects
      • 3.2.2. New Products and Innovative Service to Favor the Adoption of Sequencing
    • 3.3. Market Challenges
      • 3.3.1. Lack of Trained Technicians in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement in Polymerase Chain Reaction (PCR) and Next-Generation Sequencing Microarray (NGS)
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Personal Genome Services, by Application, Technology, Services Type, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Personal Genome Services (Value)
      • 5.2.1. Global Personal Genome Services by: Application (Value)
        • 5.2.1.1. Drug Discovery and Development
        • 5.2.1.2. Diagnostics
        • 5.2.1.3. Agriculture and Animal Research
        • 5.2.1.4. Other
      • 5.2.2. Global Personal Genome Services by: Technology (Value)
        • 5.2.2.1. Sequencing
        • 5.2.2.2. PCR
        • 5.2.2.3. Nucleic Acid Extraction and Purification
        • 5.2.2.4. Microarray
        • 5.2.2.5. Other
      • 5.2.3. Global Personal Genome Services by: Services Type (Value)
        • 5.2.3.1. NGS-based Services
        • 5.2.3.2. Core Genomics Services
        • 5.2.3.3. Biomarker Translation Services
        • 5.2.3.4. Computational Services
        • 5.2.3.5. Others
      • 5.2.4. Global Personal Genome Services by: End User (Value)
        • 5.2.4.1. Hospitals & Clinics
        • 5.2.4.2. Research Centers and Academic & Government Institutes,
        • 5.2.4.3. Pharmaceutical & Biotechnology Companies
        • 5.2.4.4. Other
      • 5.2.5. Global Personal Genome Services Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Chile
          • 5.2.5.1.4. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Singapore
          • 5.2.5.2.6. Indonesia
          • 5.2.5.2.7. Thailand
          • 5.2.5.2.8. Australia
          • 5.2.5.2.9. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Spain
          • 5.2.5.3.7. Sweden
          • 5.2.5.3.8. Belgium
          • 5.2.5.3.9. Finland
          • 5.2.5.3.10. Denmark
          • 5.2.5.3.11. Russia
          • 5.2.5.3.12. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Personal Genome Services (Volume)
      • 5.3.1. Global Personal Genome Services by: Application (Volume)
        • 5.3.1.1. Drug Discovery and Development
        • 5.3.1.2. Diagnostics
        • 5.3.1.3. Agriculture and Animal Research
        • 5.3.1.4. Other
      • 5.3.2. Global Personal Genome Services by: Technology (Volume)
        • 5.3.2.1. Sequencing
        • 5.3.2.2. PCR
        • 5.3.2.3. Nucleic Acid Extraction and Purification
        • 5.3.2.4. Microarray
        • 5.3.2.5. Other
      • 5.3.3. Global Personal Genome Services by: Services Type (Volume)
        • 5.3.3.1. NGS-based Services
        • 5.3.3.2. Core Genomics Services
        • 5.3.3.3. Biomarker Translation Services
        • 5.3.3.4. Computational Services
        • 5.3.3.5. Others
      • 5.3.4. Global Personal Genome Services by: End User (Volume)
        • 5.3.4.1. Hospitals & Clinics
        • 5.3.4.2. Research Centers and Academic & Government Institutes,
        • 5.3.4.3. Pharmaceutical & Biotechnology Companies
        • 5.3.4.4. Other
      • 5.3.5. Global Personal Genome Services Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Chile
          • 5.3.5.1.4. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Singapore
          • 5.3.5.2.6. Indonesia
          • 5.3.5.2.7. Thailand
          • 5.3.5.2.8. Australia
          • 5.3.5.2.9. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Spain
          • 5.3.5.3.7. Sweden
          • 5.3.5.3.8. Belgium
          • 5.3.5.3.9. Finland
          • 5.3.5.3.10. Denmark
          • 5.3.5.3.11. Russia
          • 5.3.5.3.12. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Personal Genome Services (Price)
  • 6. Personal Genome Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Illumina, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. 23andMe (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Veritas Genetics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Thermo Fisher Scientific (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nebula Genomics (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. 10x Genomics (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Agilent Technologies (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Invitae Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Qiagen N.V. (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Agilent Technologies, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Personal Genome Services Sale, by Application, Technology, Services Type, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Personal Genome Services (Value)
      • 7.2.1. Global Personal Genome Services by: Application (Value)
        • 7.2.1.1. Drug Discovery and Development
        • 7.2.1.2. Diagnostics
        • 7.2.1.3. Agriculture and Animal Research
        • 7.2.1.4. Other
      • 7.2.2. Global Personal Genome Services by: Technology (Value)
        • 7.2.2.1. Sequencing
        • 7.2.2.2. PCR
        • 7.2.2.3. Nucleic Acid Extraction and Purification
        • 7.2.2.4. Microarray
        • 7.2.2.5. Other
      • 7.2.3. Global Personal Genome Services by: Services Type (Value)
        • 7.2.3.1. NGS-based Services
        • 7.2.3.2. Core Genomics Services
        • 7.2.3.3. Biomarker Translation Services
        • 7.2.3.4. Computational Services
        • 7.2.3.5. Others
      • 7.2.4. Global Personal Genome Services by: End User (Value)
        • 7.2.4.1. Hospitals & Clinics
        • 7.2.4.2. Research Centers and Academic & Government Institutes,
        • 7.2.4.3. Pharmaceutical & Biotechnology Companies
        • 7.2.4.4. Other
      • 7.2.5. Global Personal Genome Services Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Chile
          • 7.2.5.1.4. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Singapore
          • 7.2.5.2.6. Indonesia
          • 7.2.5.2.7. Thailand
          • 7.2.5.2.8. Australia
          • 7.2.5.2.9. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Spain
          • 7.2.5.3.7. Sweden
          • 7.2.5.3.8. Belgium
          • 7.2.5.3.9. Finland
          • 7.2.5.3.10. Denmark
          • 7.2.5.3.11. Russia
          • 7.2.5.3.12. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Personal Genome Services (Volume)
      • 7.3.1. Global Personal Genome Services by: Application (Volume)
        • 7.3.1.1. Drug Discovery and Development
        • 7.3.1.2. Diagnostics
        • 7.3.1.3. Agriculture and Animal Research
        • 7.3.1.4. Other
      • 7.3.2. Global Personal Genome Services by: Technology (Volume)
        • 7.3.2.1. Sequencing
        • 7.3.2.2. PCR
        • 7.3.2.3. Nucleic Acid Extraction and Purification
        • 7.3.2.4. Microarray
        • 7.3.2.5. Other
      • 7.3.3. Global Personal Genome Services by: Services Type (Volume)
        • 7.3.3.1. NGS-based Services
        • 7.3.3.2. Core Genomics Services
        • 7.3.3.3. Biomarker Translation Services
        • 7.3.3.4. Computational Services
        • 7.3.3.5. Others
      • 7.3.4. Global Personal Genome Services by: End User (Volume)
        • 7.3.4.1. Hospitals & Clinics
        • 7.3.4.2. Research Centers and Academic & Government Institutes,
        • 7.3.4.3. Pharmaceutical & Biotechnology Companies
        • 7.3.4.4. Other
      • 7.3.5. Global Personal Genome Services Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Chile
          • 7.3.5.1.4. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Singapore
          • 7.3.5.2.6. Indonesia
          • 7.3.5.2.7. Thailand
          • 7.3.5.2.8. Australia
          • 7.3.5.2.9. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Spain
          • 7.3.5.3.7. Sweden
          • 7.3.5.3.8. Belgium
          • 7.3.5.3.9. Finland
          • 7.3.5.3.10. Denmark
          • 7.3.5.3.11. Russia
          • 7.3.5.3.12. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Personal Genome Services (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Personal Genome Services: by Application(USD Million)
  • Table 2. Personal Genome Services Drug Discovery and Development , by Region USD Million (2015-2020)
  • Table 3. Personal Genome Services Diagnostics , by Region USD Million (2015-2020)
  • Table 4. Personal Genome Services Agriculture and Animal Research , by Region USD Million (2015-2020)
  • Table 5. Personal Genome Services Other , by Region USD Million (2015-2020)
  • Table 6. Personal Genome Services: by Technology(USD Million)
  • Table 7. Personal Genome Services Sequencing , by Region USD Million (2015-2020)
  • Table 8. Personal Genome Services PCR , by Region USD Million (2015-2020)
  • Table 9. Personal Genome Services Nucleic Acid Extraction and Purification , by Region USD Million (2015-2020)
  • Table 10. Personal Genome Services Microarray , by Region USD Million (2015-2020)
  • Table 11. Personal Genome Services Other , by Region USD Million (2015-2020)
  • Table 12. Personal Genome Services: by Services Type(USD Million)
  • Table 13. Personal Genome Services NGS-based Services , by Region USD Million (2015-2020)
  • Table 14. Personal Genome Services Core Genomics Services , by Region USD Million (2015-2020)
  • Table 15. Personal Genome Services Biomarker Translation Services , by Region USD Million (2015-2020)
  • Table 16. Personal Genome Services Computational Services , by Region USD Million (2015-2020)
  • Table 17. Personal Genome Services Others , by Region USD Million (2015-2020)
  • Table 18. Personal Genome Services: by End User(USD Million)
  • Table 19. Personal Genome Services Hospitals & Clinics , by Region USD Million (2015-2020)
  • Table 20. Personal Genome Services Research Centers and Academic & Government Institutes, , by Region USD Million (2015-2020)
  • Table 21. Personal Genome Services Pharmaceutical & Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 22. Personal Genome Services Other , by Region USD Million (2015-2020)
  • Table 23. South America Personal Genome Services, by Country USD Million (2015-2020)
  • Table 24. South America Personal Genome Services, by Application USD Million (2015-2020)
  • Table 25. South America Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 26. South America Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 27. South America Personal Genome Services, by End User USD Million (2015-2020)
  • Table 28. Brazil Personal Genome Services, by Application USD Million (2015-2020)
  • Table 29. Brazil Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 30. Brazil Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 31. Brazil Personal Genome Services, by End User USD Million (2015-2020)
  • Table 32. Argentina Personal Genome Services, by Application USD Million (2015-2020)
  • Table 33. Argentina Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 34. Argentina Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 35. Argentina Personal Genome Services, by End User USD Million (2015-2020)
  • Table 36. Chile Personal Genome Services, by Application USD Million (2015-2020)
  • Table 37. Chile Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 38. Chile Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 39. Chile Personal Genome Services, by End User USD Million (2015-2020)
  • Table 40. Rest of South America Personal Genome Services, by Application USD Million (2015-2020)
  • Table 41. Rest of South America Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 42. Rest of South America Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 43. Rest of South America Personal Genome Services, by End User USD Million (2015-2020)
  • Table 44. Asia Pacific Personal Genome Services, by Country USD Million (2015-2020)
  • Table 45. Asia Pacific Personal Genome Services, by Application USD Million (2015-2020)
  • Table 46. Asia Pacific Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 47. Asia Pacific Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 48. Asia Pacific Personal Genome Services, by End User USD Million (2015-2020)
  • Table 49. China Personal Genome Services, by Application USD Million (2015-2020)
  • Table 50. China Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 51. China Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 52. China Personal Genome Services, by End User USD Million (2015-2020)
  • Table 53. Japan Personal Genome Services, by Application USD Million (2015-2020)
  • Table 54. Japan Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 55. Japan Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 56. Japan Personal Genome Services, by End User USD Million (2015-2020)
  • Table 57. India Personal Genome Services, by Application USD Million (2015-2020)
  • Table 58. India Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 59. India Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 60. India Personal Genome Services, by End User USD Million (2015-2020)
  • Table 61. South Korea Personal Genome Services, by Application USD Million (2015-2020)
  • Table 62. South Korea Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 63. South Korea Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 64. South Korea Personal Genome Services, by End User USD Million (2015-2020)
  • Table 65. Singapore Personal Genome Services, by Application USD Million (2015-2020)
  • Table 66. Singapore Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 67. Singapore Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 68. Singapore Personal Genome Services, by End User USD Million (2015-2020)
  • Table 69. Indonesia Personal Genome Services, by Application USD Million (2015-2020)
  • Table 70. Indonesia Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 71. Indonesia Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 72. Indonesia Personal Genome Services, by End User USD Million (2015-2020)
  • Table 73. Thailand Personal Genome Services, by Application USD Million (2015-2020)
  • Table 74. Thailand Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 75. Thailand Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 76. Thailand Personal Genome Services, by End User USD Million (2015-2020)
  • Table 77. Australia Personal Genome Services, by Application USD Million (2015-2020)
  • Table 78. Australia Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 79. Australia Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 80. Australia Personal Genome Services, by End User USD Million (2015-2020)
  • Table 81. Rest of Asia-Pacific Personal Genome Services, by Application USD Million (2015-2020)
  • Table 82. Rest of Asia-Pacific Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 83. Rest of Asia-Pacific Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 84. Rest of Asia-Pacific Personal Genome Services, by End User USD Million (2015-2020)
  • Table 85. Europe Personal Genome Services, by Country USD Million (2015-2020)
  • Table 86. Europe Personal Genome Services, by Application USD Million (2015-2020)
  • Table 87. Europe Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 88. Europe Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 89. Europe Personal Genome Services, by End User USD Million (2015-2020)
  • Table 90. Germany Personal Genome Services, by Application USD Million (2015-2020)
  • Table 91. Germany Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 92. Germany Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 93. Germany Personal Genome Services, by End User USD Million (2015-2020)
  • Table 94. France Personal Genome Services, by Application USD Million (2015-2020)
  • Table 95. France Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 96. France Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 97. France Personal Genome Services, by End User USD Million (2015-2020)
  • Table 98. Italy Personal Genome Services, by Application USD Million (2015-2020)
  • Table 99. Italy Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 100. Italy Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 101. Italy Personal Genome Services, by End User USD Million (2015-2020)
  • Table 102. United Kingdom Personal Genome Services, by Application USD Million (2015-2020)
  • Table 103. United Kingdom Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 104. United Kingdom Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 105. United Kingdom Personal Genome Services, by End User USD Million (2015-2020)
  • Table 106. Netherlands Personal Genome Services, by Application USD Million (2015-2020)
  • Table 107. Netherlands Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 108. Netherlands Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 109. Netherlands Personal Genome Services, by End User USD Million (2015-2020)
  • Table 110. Spain Personal Genome Services, by Application USD Million (2015-2020)
  • Table 111. Spain Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 112. Spain Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 113. Spain Personal Genome Services, by End User USD Million (2015-2020)
  • Table 114. Sweden Personal Genome Services, by Application USD Million (2015-2020)
  • Table 115. Sweden Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 116. Sweden Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 117. Sweden Personal Genome Services, by End User USD Million (2015-2020)
  • Table 118. Belgium Personal Genome Services, by Application USD Million (2015-2020)
  • Table 119. Belgium Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 120. Belgium Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 121. Belgium Personal Genome Services, by End User USD Million (2015-2020)
  • Table 122. Finland Personal Genome Services, by Application USD Million (2015-2020)
  • Table 123. Finland Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 124. Finland Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 125. Finland Personal Genome Services, by End User USD Million (2015-2020)
  • Table 126. Denmark Personal Genome Services, by Application USD Million (2015-2020)
  • Table 127. Denmark Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 128. Denmark Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 129. Denmark Personal Genome Services, by End User USD Million (2015-2020)
  • Table 130. Russia Personal Genome Services, by Application USD Million (2015-2020)
  • Table 131. Russia Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 132. Russia Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 133. Russia Personal Genome Services, by End User USD Million (2015-2020)
  • Table 134. Rest of Europe Personal Genome Services, by Application USD Million (2015-2020)
  • Table 135. Rest of Europe Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 136. Rest of Europe Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 137. Rest of Europe Personal Genome Services, by End User USD Million (2015-2020)
  • Table 138. MEA Personal Genome Services, by Country USD Million (2015-2020)
  • Table 139. MEA Personal Genome Services, by Application USD Million (2015-2020)
  • Table 140. MEA Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 141. MEA Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 142. MEA Personal Genome Services, by End User USD Million (2015-2020)
  • Table 143. Middle East Personal Genome Services, by Application USD Million (2015-2020)
  • Table 144. Middle East Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 145. Middle East Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 146. Middle East Personal Genome Services, by End User USD Million (2015-2020)
  • Table 147. Africa Personal Genome Services, by Application USD Million (2015-2020)
  • Table 148. Africa Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 149. Africa Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 150. Africa Personal Genome Services, by End User USD Million (2015-2020)
  • Table 151. North America Personal Genome Services, by Country USD Million (2015-2020)
  • Table 152. North America Personal Genome Services, by Application USD Million (2015-2020)
  • Table 153. North America Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 154. North America Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 155. North America Personal Genome Services, by End User USD Million (2015-2020)
  • Table 156. United States Personal Genome Services, by Application USD Million (2015-2020)
  • Table 157. United States Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 158. United States Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 159. United States Personal Genome Services, by End User USD Million (2015-2020)
  • Table 160. Canada Personal Genome Services, by Application USD Million (2015-2020)
  • Table 161. Canada Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 162. Canada Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 163. Canada Personal Genome Services, by End User USD Million (2015-2020)
  • Table 164. Mexico Personal Genome Services, by Application USD Million (2015-2020)
  • Table 165. Mexico Personal Genome Services, by Technology USD Million (2015-2020)
  • Table 166. Mexico Personal Genome Services, by Services Type USD Million (2015-2020)
  • Table 167. Mexico Personal Genome Services, by End User USD Million (2015-2020)
  • Table 168. Personal Genome Services Sales: by Application(K Units)
  • Table 169. Personal Genome Services Sales Drug Discovery and Development , by Region K Units (2015-2020)
  • Table 170. Personal Genome Services Sales Diagnostics , by Region K Units (2015-2020)
  • Table 171. Personal Genome Services Sales Agriculture and Animal Research , by Region K Units (2015-2020)
  • Table 172. Personal Genome Services Sales Other , by Region K Units (2015-2020)
  • Table 173. Personal Genome Services Sales: by Technology(K Units)
  • Table 174. Personal Genome Services Sales Sequencing , by Region K Units (2015-2020)
  • Table 175. Personal Genome Services Sales PCR , by Region K Units (2015-2020)
  • Table 176. Personal Genome Services Sales Nucleic Acid Extraction and Purification , by Region K Units (2015-2020)
  • Table 177. Personal Genome Services Sales Microarray , by Region K Units (2015-2020)
  • Table 178. Personal Genome Services Sales Other , by Region K Units (2015-2020)
  • Table 179. Personal Genome Services Sales: by Services Type(K Units)
  • Table 180. Personal Genome Services Sales NGS-based Services , by Region K Units (2015-2020)
  • Table 181. Personal Genome Services Sales Core Genomics Services , by Region K Units (2015-2020)
  • Table 182. Personal Genome Services Sales Biomarker Translation Services , by Region K Units (2015-2020)
  • Table 183. Personal Genome Services Sales Computational Services , by Region K Units (2015-2020)
  • Table 184. Personal Genome Services Sales Others , by Region K Units (2015-2020)
  • Table 185. Personal Genome Services Sales: by End User(K Units)
  • Table 186. Personal Genome Services Sales Hospitals & Clinics , by Region K Units (2015-2020)
  • Table 187. Personal Genome Services Sales Research Centers and Academic & Government Institutes, , by Region K Units (2015-2020)
  • Table 188. Personal Genome Services Sales Pharmaceutical & Biotechnology Companies , by Region K Units (2015-2020)
  • Table 189. Personal Genome Services Sales Other , by Region K Units (2015-2020)
  • Table 190. South America Personal Genome Services Sales, by Country K Units (2015-2020)
  • Table 191. South America Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 192. South America Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 193. South America Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 194. South America Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 195. Brazil Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 196. Brazil Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 197. Brazil Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 198. Brazil Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 199. Argentina Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 200. Argentina Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 201. Argentina Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 202. Argentina Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 203. Chile Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 204. Chile Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 205. Chile Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 206. Chile Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 207. Rest of South America Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 208. Rest of South America Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 209. Rest of South America Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 210. Rest of South America Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 211. Asia Pacific Personal Genome Services Sales, by Country K Units (2015-2020)
  • Table 212. Asia Pacific Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 213. Asia Pacific Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 214. Asia Pacific Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 215. Asia Pacific Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 216. China Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 217. China Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 218. China Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 219. China Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 220. Japan Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 221. Japan Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 222. Japan Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 223. Japan Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 224. India Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 225. India Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 226. India Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 227. India Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 228. South Korea Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 229. South Korea Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 230. South Korea Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 231. South Korea Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 232. Singapore Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 233. Singapore Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 234. Singapore Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 235. Singapore Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 236. Indonesia Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 237. Indonesia Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 238. Indonesia Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 239. Indonesia Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 240. Thailand Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 241. Thailand Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 242. Thailand Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 243. Thailand Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 244. Australia Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 245. Australia Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 246. Australia Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 247. Australia Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 248. Rest of Asia-Pacific Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 249. Rest of Asia-Pacific Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 250. Rest of Asia-Pacific Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 251. Rest of Asia-Pacific Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 252. Europe Personal Genome Services Sales, by Country K Units (2015-2020)
  • Table 253. Europe Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 254. Europe Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 255. Europe Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 256. Europe Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 257. Germany Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 258. Germany Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 259. Germany Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 260. Germany Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 261. France Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 262. France Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 263. France Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 264. France Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 265. Italy Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 266. Italy Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 267. Italy Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 268. Italy Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 269. United Kingdom Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 270. United Kingdom Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 271. United Kingdom Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 272. United Kingdom Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 273. Netherlands Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 274. Netherlands Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 275. Netherlands Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 276. Netherlands Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 277. Spain Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 278. Spain Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 279. Spain Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 280. Spain Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 281. Sweden Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 282. Sweden Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 283. Sweden Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 284. Sweden Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 285. Belgium Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 286. Belgium Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 287. Belgium Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 288. Belgium Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 289. Finland Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 290. Finland Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 291. Finland Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 292. Finland Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 293. Denmark Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 294. Denmark Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 295. Denmark Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 296. Denmark Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 297. Russia Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 298. Russia Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 299. Russia Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 300. Russia Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 301. Rest of Europe Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 302. Rest of Europe Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 303. Rest of Europe Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 304. Rest of Europe Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 305. MEA Personal Genome Services Sales, by Country K Units (2015-2020)
  • Table 306. MEA Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 307. MEA Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 308. MEA Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 309. MEA Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 310. Middle East Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 311. Middle East Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 312. Middle East Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 313. Middle East Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 314. Africa Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 315. Africa Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 316. Africa Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 317. Africa Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 318. North America Personal Genome Services Sales, by Country K Units (2015-2020)
  • Table 319. North America Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 320. North America Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 321. North America Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 322. North America Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 323. United States Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 324. United States Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 325. United States Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 326. United States Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 327. Canada Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 328. Canada Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 329. Canada Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 330. Canada Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 331. Mexico Personal Genome Services Sales, by Application K Units (2015-2020)
  • Table 332. Mexico Personal Genome Services Sales, by Technology K Units (2015-2020)
  • Table 333. Mexico Personal Genome Services Sales, by Services Type K Units (2015-2020)
  • Table 334. Mexico Personal Genome Services Sales, by End User K Units (2015-2020)
  • Table 335. Company Basic Information, Sales Area and Its Competitors
  • Table 336. Company Basic Information, Sales Area and Its Competitors
  • Table 337. Company Basic Information, Sales Area and Its Competitors
  • Table 338. Company Basic Information, Sales Area and Its Competitors
  • Table 339. Company Basic Information, Sales Area and Its Competitors
  • Table 340. Company Basic Information, Sales Area and Its Competitors
  • Table 341. Company Basic Information, Sales Area and Its Competitors
  • Table 342. Company Basic Information, Sales Area and Its Competitors
  • Table 343. Company Basic Information, Sales Area and Its Competitors
  • Table 344. Company Basic Information, Sales Area and Its Competitors
  • Table 345. Company Basic Information, Sales Area and Its Competitors
  • Table 346. Personal Genome Services: by Application(USD Million)
  • Table 347. Personal Genome Services Drug Discovery and Development , by Region USD Million (2021-2026)
  • Table 348. Personal Genome Services Diagnostics , by Region USD Million (2021-2026)
  • Table 349. Personal Genome Services Agriculture and Animal Research , by Region USD Million (2021-2026)
  • Table 350. Personal Genome Services Other , by Region USD Million (2021-2026)
  • Table 351. Personal Genome Services: by Technology(USD Million)
  • Table 352. Personal Genome Services Sequencing , by Region USD Million (2021-2026)
  • Table 353. Personal Genome Services PCR , by Region USD Million (2021-2026)
  • Table 354. Personal Genome Services Nucleic Acid Extraction and Purification , by Region USD Million (2021-2026)
  • Table 355. Personal Genome Services Microarray , by Region USD Million (2021-2026)
  • Table 356. Personal Genome Services Other , by Region USD Million (2021-2026)
  • Table 357. Personal Genome Services: by Services Type(USD Million)
  • Table 358. Personal Genome Services NGS-based Services , by Region USD Million (2021-2026)
  • Table 359. Personal Genome Services Core Genomics Services , by Region USD Million (2021-2026)
  • Table 360. Personal Genome Services Biomarker Translation Services , by Region USD Million (2021-2026)
  • Table 361. Personal Genome Services Computational Services , by Region USD Million (2021-2026)
  • Table 362. Personal Genome Services Others , by Region USD Million (2021-2026)
  • Table 363. Personal Genome Services: by End User(USD Million)
  • Table 364. Personal Genome Services Hospitals & Clinics , by Region USD Million (2021-2026)
  • Table 365. Personal Genome Services Research Centers and Academic & Government Institutes, , by Region USD Million (2021-2026)
  • Table 366. Personal Genome Services Pharmaceutical & Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 367. Personal Genome Services Other , by Region USD Million (2021-2026)
  • Table 368. South America Personal Genome Services, by Country USD Million (2021-2026)
  • Table 369. South America Personal Genome Services, by Application USD Million (2021-2026)
  • Table 370. South America Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 371. South America Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 372. South America Personal Genome Services, by End User USD Million (2021-2026)
  • Table 373. Brazil Personal Genome Services, by Application USD Million (2021-2026)
  • Table 374. Brazil Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 375. Brazil Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 376. Brazil Personal Genome Services, by End User USD Million (2021-2026)
  • Table 377. Argentina Personal Genome Services, by Application USD Million (2021-2026)
  • Table 378. Argentina Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 379. Argentina Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 380. Argentina Personal Genome Services, by End User USD Million (2021-2026)
  • Table 381. Chile Personal Genome Services, by Application USD Million (2021-2026)
  • Table 382. Chile Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 383. Chile Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 384. Chile Personal Genome Services, by End User USD Million (2021-2026)
  • Table 385. Rest of South America Personal Genome Services, by Application USD Million (2021-2026)
  • Table 386. Rest of South America Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 387. Rest of South America Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 388. Rest of South America Personal Genome Services, by End User USD Million (2021-2026)
  • Table 389. Asia Pacific Personal Genome Services, by Country USD Million (2021-2026)
  • Table 390. Asia Pacific Personal Genome Services, by Application USD Million (2021-2026)
  • Table 391. Asia Pacific Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 392. Asia Pacific Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 393. Asia Pacific Personal Genome Services, by End User USD Million (2021-2026)
  • Table 394. China Personal Genome Services, by Application USD Million (2021-2026)
  • Table 395. China Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 396. China Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 397. China Personal Genome Services, by End User USD Million (2021-2026)
  • Table 398. Japan Personal Genome Services, by Application USD Million (2021-2026)
  • Table 399. Japan Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 400. Japan Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 401. Japan Personal Genome Services, by End User USD Million (2021-2026)
  • Table 402. India Personal Genome Services, by Application USD Million (2021-2026)
  • Table 403. India Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 404. India Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 405. India Personal Genome Services, by End User USD Million (2021-2026)
  • Table 406. South Korea Personal Genome Services, by Application USD Million (2021-2026)
  • Table 407. South Korea Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 408. South Korea Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 409. South Korea Personal Genome Services, by End User USD Million (2021-2026)
  • Table 410. Singapore Personal Genome Services, by Application USD Million (2021-2026)
  • Table 411. Singapore Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 412. Singapore Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 413. Singapore Personal Genome Services, by End User USD Million (2021-2026)
  • Table 414. Indonesia Personal Genome Services, by Application USD Million (2021-2026)
  • Table 415. Indonesia Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 416. Indonesia Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 417. Indonesia Personal Genome Services, by End User USD Million (2021-2026)
  • Table 418. Thailand Personal Genome Services, by Application USD Million (2021-2026)
  • Table 419. Thailand Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 420. Thailand Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 421. Thailand Personal Genome Services, by End User USD Million (2021-2026)
  • Table 422. Australia Personal Genome Services, by Application USD Million (2021-2026)
  • Table 423. Australia Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 424. Australia Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 425. Australia Personal Genome Services, by End User USD Million (2021-2026)
  • Table 426. Rest of Asia-Pacific Personal Genome Services, by Application USD Million (2021-2026)
  • Table 427. Rest of Asia-Pacific Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 428. Rest of Asia-Pacific Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 429. Rest of Asia-Pacific Personal Genome Services, by End User USD Million (2021-2026)
  • Table 430. Europe Personal Genome Services, by Country USD Million (2021-2026)
  • Table 431. Europe Personal Genome Services, by Application USD Million (2021-2026)
  • Table 432. Europe Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 433. Europe Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 434. Europe Personal Genome Services, by End User USD Million (2021-2026)
  • Table 435. Germany Personal Genome Services, by Application USD Million (2021-2026)
  • Table 436. Germany Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 437. Germany Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 438. Germany Personal Genome Services, by End User USD Million (2021-2026)
  • Table 439. France Personal Genome Services, by Application USD Million (2021-2026)
  • Table 440. France Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 441. France Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 442. France Personal Genome Services, by End User USD Million (2021-2026)
  • Table 443. Italy Personal Genome Services, by Application USD Million (2021-2026)
  • Table 444. Italy Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 445. Italy Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 446. Italy Personal Genome Services, by End User USD Million (2021-2026)
  • Table 447. United Kingdom Personal Genome Services, by Application USD Million (2021-2026)
  • Table 448. United Kingdom Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 449. United Kingdom Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 450. United Kingdom Personal Genome Services, by End User USD Million (2021-2026)
  • Table 451. Netherlands Personal Genome Services, by Application USD Million (2021-2026)
  • Table 452. Netherlands Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 453. Netherlands Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 454. Netherlands Personal Genome Services, by End User USD Million (2021-2026)
  • Table 455. Spain Personal Genome Services, by Application USD Million (2021-2026)
  • Table 456. Spain Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 457. Spain Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 458. Spain Personal Genome Services, by End User USD Million (2021-2026)
  • Table 459. Sweden Personal Genome Services, by Application USD Million (2021-2026)
  • Table 460. Sweden Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 461. Sweden Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 462. Sweden Personal Genome Services, by End User USD Million (2021-2026)
  • Table 463. Belgium Personal Genome Services, by Application USD Million (2021-2026)
  • Table 464. Belgium Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 465. Belgium Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 466. Belgium Personal Genome Services, by End User USD Million (2021-2026)
  • Table 467. Finland Personal Genome Services, by Application USD Million (2021-2026)
  • Table 468. Finland Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 469. Finland Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 470. Finland Personal Genome Services, by End User USD Million (2021-2026)
  • Table 471. Denmark Personal Genome Services, by Application USD Million (2021-2026)
  • Table 472. Denmark Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 473. Denmark Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 474. Denmark Personal Genome Services, by End User USD Million (2021-2026)
  • Table 475. Russia Personal Genome Services, by Application USD Million (2021-2026)
  • Table 476. Russia Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 477. Russia Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 478. Russia Personal Genome Services, by End User USD Million (2021-2026)
  • Table 479. Rest of Europe Personal Genome Services, by Application USD Million (2021-2026)
  • Table 480. Rest of Europe Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 481. Rest of Europe Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 482. Rest of Europe Personal Genome Services, by End User USD Million (2021-2026)
  • Table 483. MEA Personal Genome Services, by Country USD Million (2021-2026)
  • Table 484. MEA Personal Genome Services, by Application USD Million (2021-2026)
  • Table 485. MEA Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 486. MEA Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 487. MEA Personal Genome Services, by End User USD Million (2021-2026)
  • Table 488. Middle East Personal Genome Services, by Application USD Million (2021-2026)
  • Table 489. Middle East Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 490. Middle East Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 491. Middle East Personal Genome Services, by End User USD Million (2021-2026)
  • Table 492. Africa Personal Genome Services, by Application USD Million (2021-2026)
  • Table 493. Africa Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 494. Africa Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 495. Africa Personal Genome Services, by End User USD Million (2021-2026)
  • Table 496. North America Personal Genome Services, by Country USD Million (2021-2026)
  • Table 497. North America Personal Genome Services, by Application USD Million (2021-2026)
  • Table 498. North America Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 499. North America Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 500. North America Personal Genome Services, by End User USD Million (2021-2026)
  • Table 501. United States Personal Genome Services, by Application USD Million (2021-2026)
  • Table 502. United States Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 503. United States Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 504. United States Personal Genome Services, by End User USD Million (2021-2026)
  • Table 505. Canada Personal Genome Services, by Application USD Million (2021-2026)
  • Table 506. Canada Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 507. Canada Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 508. Canada Personal Genome Services, by End User USD Million (2021-2026)
  • Table 509. Mexico Personal Genome Services, by Application USD Million (2021-2026)
  • Table 510. Mexico Personal Genome Services, by Technology USD Million (2021-2026)
  • Table 511. Mexico Personal Genome Services, by Services Type USD Million (2021-2026)
  • Table 512. Mexico Personal Genome Services, by End User USD Million (2021-2026)
  • Table 513. Personal Genome Services Sales: by Application(K Units)
  • Table 514. Personal Genome Services Sales Drug Discovery and Development , by Region K Units (2021-2026)
  • Table 515. Personal Genome Services Sales Diagnostics , by Region K Units (2021-2026)
  • Table 516. Personal Genome Services Sales Agriculture and Animal Research , by Region K Units (2021-2026)
  • Table 517. Personal Genome Services Sales Other , by Region K Units (2021-2026)
  • Table 518. Personal Genome Services Sales: by Technology(K Units)
  • Table 519. Personal Genome Services Sales Sequencing , by Region K Units (2021-2026)
  • Table 520. Personal Genome Services Sales PCR , by Region K Units (2021-2026)
  • Table 521. Personal Genome Services Sales Nucleic Acid Extraction and Purification , by Region K Units (2021-2026)
  • Table 522. Personal Genome Services Sales Microarray , by Region K Units (2021-2026)
  • Table 523. Personal Genome Services Sales Other , by Region K Units (2021-2026)
  • Table 524. Personal Genome Services Sales: by Services Type(K Units)
  • Table 525. Personal Genome Services Sales NGS-based Services , by Region K Units (2021-2026)
  • Table 526. Personal Genome Services Sales Core Genomics Services , by Region K Units (2021-2026)
  • Table 527. Personal Genome Services Sales Biomarker Translation Services , by Region K Units (2021-2026)
  • Table 528. Personal Genome Services Sales Computational Services , by Region K Units (2021-2026)
  • Table 529. Personal Genome Services Sales Others , by Region K Units (2021-2026)
  • Table 530. Personal Genome Services Sales: by End User(K Units)
  • Table 531. Personal Genome Services Sales Hospitals & Clinics , by Region K Units (2021-2026)
  • Table 532. Personal Genome Services Sales Research Centers and Academic & Government Institutes, , by Region K Units (2021-2026)
  • Table 533. Personal Genome Services Sales Pharmaceutical & Biotechnology Companies , by Region K Units (2021-2026)
  • Table 534. Personal Genome Services Sales Other , by Region K Units (2021-2026)
  • Table 535. South America Personal Genome Services Sales, by Country K Units (2021-2026)
  • Table 536. South America Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 537. South America Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 538. South America Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 539. South America Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 540. Brazil Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 541. Brazil Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 542. Brazil Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 543. Brazil Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 544. Argentina Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 545. Argentina Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 546. Argentina Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 547. Argentina Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 548. Chile Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 549. Chile Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 550. Chile Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 551. Chile Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 552. Rest of South America Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 553. Rest of South America Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 554. Rest of South America Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 555. Rest of South America Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 556. Asia Pacific Personal Genome Services Sales, by Country K Units (2021-2026)
  • Table 557. Asia Pacific Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 558. Asia Pacific Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 559. Asia Pacific Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 560. Asia Pacific Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 561. China Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 562. China Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 563. China Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 564. China Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 565. Japan Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 566. Japan Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 567. Japan Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 568. Japan Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 569. India Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 570. India Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 571. India Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 572. India Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 573. South Korea Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 574. South Korea Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 575. South Korea Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 576. South Korea Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 577. Singapore Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 578. Singapore Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 579. Singapore Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 580. Singapore Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 581. Indonesia Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 582. Indonesia Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 583. Indonesia Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 584. Indonesia Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 585. Thailand Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 586. Thailand Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 587. Thailand Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 588. Thailand Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 589. Australia Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 590. Australia Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 591. Australia Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 592. Australia Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 593. Rest of Asia-Pacific Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 594. Rest of Asia-Pacific Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 595. Rest of Asia-Pacific Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 596. Rest of Asia-Pacific Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 597. Europe Personal Genome Services Sales, by Country K Units (2021-2026)
  • Table 598. Europe Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 599. Europe Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 600. Europe Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 601. Europe Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 602. Germany Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 603. Germany Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 604. Germany Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 605. Germany Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 606. France Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 607. France Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 608. France Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 609. France Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 610. Italy Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 611. Italy Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 612. Italy Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 613. Italy Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 614. United Kingdom Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 615. United Kingdom Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 616. United Kingdom Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 617. United Kingdom Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 618. Netherlands Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 619. Netherlands Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 620. Netherlands Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 621. Netherlands Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 622. Spain Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 623. Spain Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 624. Spain Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 625. Spain Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 626. Sweden Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 627. Sweden Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 628. Sweden Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 629. Sweden Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 630. Belgium Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 631. Belgium Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 632. Belgium Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 633. Belgium Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 634. Finland Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 635. Finland Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 636. Finland Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 637. Finland Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 638. Denmark Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 639. Denmark Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 640. Denmark Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 641. Denmark Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 642. Russia Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 643. Russia Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 644. Russia Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 645. Russia Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 646. Rest of Europe Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 647. Rest of Europe Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 648. Rest of Europe Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 649. Rest of Europe Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 650. MEA Personal Genome Services Sales, by Country K Units (2021-2026)
  • Table 651. MEA Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 652. MEA Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 653. MEA Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 654. MEA Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 655. Middle East Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 656. Middle East Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 657. Middle East Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 658. Middle East Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 659. Africa Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 660. Africa Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 661. Africa Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 662. Africa Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 663. North America Personal Genome Services Sales, by Country K Units (2021-2026)
  • Table 664. North America Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 665. North America Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 666. North America Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 667. North America Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 668. United States Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 669. United States Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 670. United States Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 671. United States Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 672. Canada Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 673. Canada Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 674. Canada Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 675. Canada Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 676. Mexico Personal Genome Services Sales, by Application K Units (2021-2026)
  • Table 677. Mexico Personal Genome Services Sales, by Technology K Units (2021-2026)
  • Table 678. Mexico Personal Genome Services Sales, by Services Type K Units (2021-2026)
  • Table 679. Mexico Personal Genome Services Sales, by End User K Units (2021-2026)
  • Table 680. Research Programs/Design for This Report
  • Table 681. Key Data Information from Secondary Sources
  • Table 682. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Personal Genome Services: by Application USD Million (2015-2020)
  • Figure 5. Global Personal Genome Services: by Technology USD Million (2015-2020)
  • Figure 6. Global Personal Genome Services: by Services Type USD Million (2015-2020)
  • Figure 7. Global Personal Genome Services: by End User USD Million (2015-2020)
  • Figure 8. South America Personal Genome Services Share (%), by Country
  • Figure 9. Asia Pacific Personal Genome Services Share (%), by Country
  • Figure 10. Europe Personal Genome Services Share (%), by Country
  • Figure 11. MEA Personal Genome Services Share (%), by Country
  • Figure 12. North America Personal Genome Services Share (%), by Country
  • Figure 13. Global Personal Genome Services: by Application K Units (2015-2020)
  • Figure 14. Global Personal Genome Services: by Technology K Units (2015-2020)
  • Figure 15. Global Personal Genome Services: by Services Type K Units (2015-2020)
  • Figure 16. Global Personal Genome Services: by End User K Units (2015-2020)
  • Figure 17. South America Personal Genome Services Share (%), by Country
  • Figure 18. Asia Pacific Personal Genome Services Share (%), by Country
  • Figure 19. Europe Personal Genome Services Share (%), by Country
  • Figure 20. MEA Personal Genome Services Share (%), by Country
  • Figure 21. North America Personal Genome Services Share (%), by Country
  • Figure 22. Global Personal Genome Services share by Players 2020 (%)
  • Figure 23. Global Personal Genome Services share by Players (Top 3) 2020(%)
  • Figure 24. Global Personal Genome Services share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Illumina, Inc. (United States) Revenue: by Geography 2020
  • Figure 28. 23andMe (United States) Revenue, Net Income and Gross profit
  • Figure 29. 23andMe (United States) Revenue: by Geography 2020
  • Figure 30. Veritas Genetics (United States) Revenue, Net Income and Gross profit
  • Figure 31. Veritas Genetics (United States) Revenue: by Geography 2020
  • Figure 32. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 33. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 34. Nebula Genomics (United States) Revenue, Net Income and Gross profit
  • Figure 35. Nebula Genomics (United States) Revenue: by Geography 2020
  • Figure 36. 10x Genomics (United States) Revenue, Net Income and Gross profit
  • Figure 37. 10x Genomics (United States) Revenue: by Geography 2020
  • Figure 38. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 39. Agilent Technologies (United States) Revenue: by Geography 2020
  • Figure 40. Invitae Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 41. Invitae Corporation (United States) Revenue: by Geography 2020
  • Figure 42. Qiagen N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 43. Qiagen N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 44. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 45. Agilent Technologies, Inc. (United States) Revenue: by Geography 2020
  • Figure 46. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 47. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 48. Global Personal Genome Services: by Application USD Million (2021-2026)
  • Figure 49. Global Personal Genome Services: by Technology USD Million (2021-2026)
  • Figure 50. Global Personal Genome Services: by Services Type USD Million (2021-2026)
  • Figure 51. Global Personal Genome Services: by End User USD Million (2021-2026)
  • Figure 52. South America Personal Genome Services Share (%), by Country
  • Figure 53. Asia Pacific Personal Genome Services Share (%), by Country
  • Figure 54. Europe Personal Genome Services Share (%), by Country
  • Figure 55. MEA Personal Genome Services Share (%), by Country
  • Figure 56. North America Personal Genome Services Share (%), by Country
  • Figure 57. Global Personal Genome Services: by Application K Units (2021-2026)
  • Figure 58. Global Personal Genome Services: by Technology K Units (2021-2026)
  • Figure 59. Global Personal Genome Services: by Services Type K Units (2021-2026)
  • Figure 60. Global Personal Genome Services: by End User K Units (2021-2026)
  • Figure 61. South America Personal Genome Services Share (%), by Country
  • Figure 62. Asia Pacific Personal Genome Services Share (%), by Country
  • Figure 63. Europe Personal Genome Services Share (%), by Country
  • Figure 64. MEA Personal Genome Services Share (%), by Country
  • Figure 65. North America Personal Genome Services Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Illumina, Inc. (United States)
  • 23andMe (United States)
  • Veritas Genetics (United States)
  • Thermo Fisher Scientific (United States)
  • Nebula Genomics (United States)
  • 10x Genomics (United States)
  • Agilent Technologies (United States)
  • Invitae Corporation (United States)
  • Qiagen N.V. (Netherlands)
  • Agilent Technologies, Inc. (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
Additional players considered in the study are as follows:
Bio-Rad Laboratories, Inc. (United States) , BGI (China) , IntegraGen (France)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation